Medication info

Hyunseu Chlorpheniramine Maleate Injection Solution

Prescription medicationInjections
Ingredient · strength
Chlorpheniramine Maleate›2mg / 1mL
Manufacturer / importer
(주)휴온스
Appearance
Brown ampoule injection containing a colorless liquid
Packaging
2mL x 50 ampoules
Approval status
Active

MFDS item code 197500570 · Notified 1975.07.28 · Insurance code 670603013

Summary

Main use
Improvement of hay fever, urticaria, and pruritic skin diseases (eczema, dermatitis)
Who uses it
Adults
Adult dosage
Oral: Administer as chlorpheniramine maleate at a dose of 2-6 mg twice to four times a day. The maximum daily dose should not exceed 24 mg. Injection: Administer as chlorpheniramine maleate at a dose of 5-10 mg once or twice daily by subcutaneous, intramuscular, or intravenous injection.

Ingredients

Manufacturer
(주)휴온스

Efficacy & effects

Improvement of hay fever, urticaria, and pruritic skin diseases (eczema, dermatitis)

  • Acute urticaria
  • hives
  • pruritic skin diseases
  • eczema
  • dermatitis
  • pruritus
  • exanthema
  • insect bites
  • allergic rhinitis
  • vasomotor rhinitis
View approved original text

This medication is used for allergic reactions that appear on the skin, such as acute urticaria and hives, as well as pruritic skin diseases like eczema, dermatitis, pruritus, exanthema, insect bites, etc. It is also effective in alleviating nasal allergy symptoms such as allergic rhinitis and vasomotor rhinitis. This medication helps improve overall allergic symptoms.

Dosage and Administration

Adult dosage

Oral: Administer as chlorpheniramine maleate at a dose of 2-6 mg twice to four times a day. The maximum daily dose should not exceed 24 mg. Injection: Administer as chlorpheniramine maleate at a dose of 5-10 mg once or twice daily by subcutaneous, intramuscular, or intravenous injection.

Precautions

This medication is in injectable form, and care must be taken when cutting glass ampoules to avoid glass fragments entering. Extra caution is required, especially when used in children or the elderly. The benzyl alcohol in this medication can cause severe respiratory issues in premature infants, so it should not be administered to premature or neonate infants. This medication should not be administered to patients with allergies to this drug or similar components, glaucoma patients, patients with benign prostatic hyperplasia, or patients taking MAO inhibitors. Patients with increased intraocular pressure, hyperthyroidism, peptic ulcers, cardiovascular diseases, epilepsy, bronchial diseases, or liver diseases should use this medication cautiously. During administration, conditions such as shock, convulsions, blood abnormalities, skin rashes, neurological disturbances, gastrointestinal problems, urination difficulties, heart side effects, and respiratory symptoms may occur, so the condition should be monitored closely. This medication may cause drowsiness, so it is advisable to avoid driving or operating hazardous machinery. Caution should be exercised as taking it with alcohol or central nervous system depressants may increase drowsiness. Women who are pregnant or breastfeeding should cautiously use this medication only when necessary, as its safety has not been established. In cases of overdose in children, hallucinations, agitation, convulsions, and, in severe cases, death may occur, so special attention is required. The elderly may have decreased bodily functions, so administration should be done while monitoring their condition closely. In cases of overdose, serious side effects on the central nervous system and heart may occur, requiring immediate medical attention.

Side effects and when to seek care immediately

Serious side effects

  • Urticaria
  • cyanosis
  • dyspnea
  • chest discomfort
  • hypotension
  • seizures
  • confusion
  • aplastic anemia
  • agranulocytosis
  • hypersensitivity
Show 2 more
  • hepatitis
  • jaundice

Mild side effects

  • Rash
  • photosensitivity
  • exfoliative dermatitis
  • spasms
  • muscle weakness
  • inability to cooperate
  • sedation
  • drowsiness
  • nervousness
  • headache
Show 30 more
  • agitation
  • diplopia
  • insomnia
  • dizziness
  • tinnitus
  • vestibular disorders
  • hyperesthesia
  • emotional instability
  • hysteria
  • tremors
  • neuropathy
  • coordination issues
  • sensory abnormalities
  • neglect
  • decreased concentration
  • lethargy
  • dry mouth
  • chest discomfort
  • loss of appetite
  • dyspepsia
  • nausea
  • vomiting
  • abdominal pain
  • constipation
  • diarrhea
  • frequent urination
  • urination difficulties
  • urinary retention
  • hypoguesia
  • hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a sealed container that does not allow light in. It is recommended to maintain the storage temperature between 1°C and 30°C at room temperature.

Appearance and packaging

Appearance

Brown ampoule injection containing a colorless liquid

Package unit

2mL x 50 ampoules

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.